New sleep drug aims to ease insomnia in depressed patients
NCT ID NCT07555743
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tests whether daridorexant, a sleep medication, can reduce insomnia and improve mood in adults with major depressive disorder and insomnia. About 134 participants will receive either the drug or a placebo for three months. They will track sleep and depression symptoms through questionnaires and sleep monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitari de Bellvitge
Barcelona, Catalonia, 08908, Spain
Conditions
Explore the condition pages connected to this study.